Expression of the E2F family of transcription factors and its clinical relevance in ovarian cancer

Annals of the New York Academy of Sciences

Volumn 1091, Issue , 2006, Pages 270-281

  Reimer, Daniel ^a   Sadr, Susann ^a   Wiedemair, Annemarie ^a   Goebel, Georg ^a   Concin, Nicole ^a   Hofstetter, Gerda ^a   Marth, Christian ^a   Zeimet, Alain G ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

E2F; EGF; Ovarian cancer; Transcription factor; Tumor progression

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F8; UNCLASSIFIED DRUG; E2F8 PROTEIN, HUMAN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR E2F2;

CANCER GRADING; CANCER PATIENT; CONFERENCE PAPER; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; PERITONEUM MESOTHELIOMA; PROTEIN FAMILY; TUMOR VOLUME; UPREGULATION; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MULTIGENE FAMILY; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; E2F2 TRANSCRIPTION FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MULTIGENE FAMILY; OVARIAN NEOPLASMS; REPRESSOR PROTEINS;

EID: 33947587272     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1378.073     Document Type: Conference Paper

References (17)

1. KOVESDI, I. et al. 1986. Identification of a cellular transcription factor involved in E1A trans-activation. Cell 45: 219-228. review.
2. BLACK, A.R. & J. AZIZKHAN-CLIFFORD. 1999. Regulation of E2F: a family of transcription factors involved in proliferation control. Gene 237: 281-302. review.
3. DEGREGORI, J. 2002. The genetics of the E2F family of transcription factors: shared functions and unique roles. Biochim. Biophys. Acta 21; 1602: 131-150. Review.
4. STEVENS, C. & N.B. LA THANGUE. 2003. E2F and cell cycle control: a double-edged sword. Arch. Biochem. Biophys. 15; 412: 157-169. Review.
5. DIMOVA, D.K. & N.J. DYSON. 2005. The E2F transcriptional network: old acquaintances with new faces [review]. Oncogene 24: 2810-2826.
6. ATTWOOLL, C. et al. 2004. The E2F family: specific functions and overlapping interests [Review]. EMBO J. 23: 4709-4716.
7. MAITI, B. et al. 2005. Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation. J. Biol. Chem. 280: 18211-18220.
8. CHRISTENSEN, J. et al. 2005. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription. Nucleic Acids Res. 33: 5458-5470.
9. GORGOULIS, V.G. et al. 2002.Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas. J. Pathol. 198: 142-156.
10. EBIHARA, Y. et al. 2004. Over-expression of E2F-1 in esophageal squamous cell carcinoma correlates with tumor progression. Dis. Esophagus 17: 150-154.
11. NEVINS, J.R. 2001. The Rb/E2F pathway and cancer. Hum. Mol. Genet. 10: 699-703. Review.
12. FOSTER, C.S. et al. 2004. Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome. Oncogene 23: 5871-5879.
13. FEBER, A. et al. 2004. Amplification and overexpression of E2F3 in human bladder cancer. Oncogene 23: 1627-1630.
14. OEGGERLI, M. et al. 2004. E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Oncogene 23: 5616-5623.
15. SHERR, C.J. 1996. Cancer cell cycles [review]. Science 6; 274: 1672-1677.
16. DENCHI, E.L. & K. HELIN. 2005. E2F1 is crucial for E2F-dependent apoptosis. EMBO Rep. 6: 661-668.
17. PAULSON, Q.X. et al. 2006. E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model. Cell Cycle 5: 184-190.